Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 3,600 | 3,822 | 3,631 | 2,998 | 3,049 |
| Cost of Goods | 344 | 431 | 348 | 167 | 192 |
| Gross Profit | 3,256 | 3,391 | 3,283 | 2,831 | 2,857 |
| Operating Expenses | 16,469 | 15,158 | 15,171 | 17,172 | 15,543 |
| Operating Income | -12,869 | -11,336 | -11,540 | -14,174 | -12,494 |
| Other Income | 49 | 76 | 45 | 306 | 568 |
| Pre-tax Income | -12,820 | -11,260 | -11,495 | -13,868 | -11,926 |
| Income Tax | N/A | N/A | -194 | N/A | N/A |
| Net Income Continuous | -12,820 | -11,260 | -11,301 | -13,868 | -11,926 |
| Net Income | $-12,820 | $-11,260 | $-11,301 | $-13,868 | $-11,926 |
| EPS Basic Total Ops | -489.85 | -433.87 | -433.87 | -531.84 | -461.86 |
| EPS Basic Continuous Ops | -492.67 | -432.74 | -434.46 | -533.58 | -459.20 |
| EPS Diluted Total Ops | -489.85 | -433.87 | -433.87 | -531.84 | -461.86 |
| EPS Diluted Continuous Ops | -492.67 | -432.74 | -434.46 | -533.58 | -459.20 |
| EBITDA(a) | $-15,318 | $-13,764 | $-13,954 | $-16,479 | $-14,788 |